Vimarsana
Biggest News Aggregation in the World

Proteomics Core Facility News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Proteomics Core Facility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Proteomics Core Facility Today - Breaking & Trending Today

The CRL5–SPSB3 ubiquitin ligase targets nuclear cGAS for degradation - Vimarsana News

The CRL5–SPSB3 ubiquitin ligase targets nuclear cGAS for degradation

Cyclic GMP-AMP synthase (cGAS) senses aberrant DNA during infection, cancer and inflammatory disease, and initiates potent innate immune responses through the synthesis of 2′3′-cyclic GMP-AMP (cGAMP)1–7. The indiscriminate activity of cGAS towards DNA demands tight regulatory mechanisms that are necessary to maintain cell and tissue homeostasis under normal conditions. Inside the cell nucleus, anchoring to nucleosomes and competition with chromatin architectural proteins jointly prohibit cGAS activation by genomic DNA8–15. However, the fate of nuclear cGAS and its role ...

Source: nature.com
Hendrix awards alumni Odyssey medals - Vimarsana News

Hendrix awards alumni Odyssey medals

Hendrix College awarded Odyssey medals to alumni whose life achievements exemplify the ideals of the Hendrix Odyssey Program on Thursday.

Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy - Vimarsana News

Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy

Significance Statement Membranous nephropathy (MN) is an autoimmune disease caused by circulating

Investegate |Olink Proteomics AB Announcements | Olink Proteomics AB: Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapies - Vimarsana News

Investegate |Olink Proteomics AB Announcements | Olink Proteomics AB: Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapies

Investegate announcements from Olink Proteomics AB, Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapies

Online Exchange Connects Arkansas Researchers With Equipment - Vimarsana News

Online Exchange Connects Arkansas Researchers With Equipment

One goal of program's goals is to help the state avoid the duplication of research dollars.